Commentary

Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The discovery can lead to new...

Researchers identify a molecular strategy that human melanoma cells use to resist immunotherapy, and develop a new approach to combat the resistance in mouse models. Unleashing the immune system to fight tumors — an approach enabled by...

The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but...

New findings add to growing evidence that previously dismissed "junk DNA" actually produces RNA molecules with important regulatory functions Scientists have identified an RNA molecule with broad powers to regulate the body's inflammatory...

Stanford scientists and their collaborators have identified two key genes responsible for the rapid growth of deer antlers. They hope their insights...

In-depth analysis sorts cells from the cerebral cortex into 133 types, lays groundwork to explore function undefined. Neuroscientists used a new, gene-based classification of mouse brain cell types and additional...

Men who want to have children in the near future should consider hitting the gym. In a new study led by Kristin Stanford, a physiology and cell biology...

Resistance to therapy is common in estrogen receptor positive (ER+) breast cancer, the most common type of breast cancer, and eventual development of metastatic disease is a leading cause of death. Exploring what sets breast cancer cells on a path ...

A deep neural network algorithm called BOTA uses bacterial genomes to identify unrecognized bacterial antigens. The immune system keeps T cells under...

RNA sequencing can help improve the diagnostic rate of exome and genome sequencing-based tests for genetic disease, according to a new study presented at the American Society for Human Genetics' annual meeting in San Diego this week. Despite the success...